Drugs for hypertension.
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D003000:Clonidine / Q000627:therapeutic use; D003863:Depression / Q000139:chemically induced; D004232:Diuretics; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005665:Furosemide / Q000009:adverse effects; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D008750:Methyldopa / Q000009:adverse effects; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011188:Potassium / Q000378:metabolism; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D008996:Monoamine Oxidase Inhibitors; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents; D013148:Spironolactone; D008750:Methyldopa; D005665:Furosemide; D012110:Reserpine; D011433:Propranolol; D003000:Clonidine; D011188:Potassium; D014223:Triamterene; D006145:Guanethidine